RA Capital Nexus Fund II, 10% Owner: AN2 Therapeutics ANTX Sell · Filed 24/08/13

Trade details

Type: Insider sale
Amount: $3,683,161.8
Shares · price: 3,410,335 sh · $1.08 a share
Held after: 1,725,348 sh
Stock: AN2 Therapeutics ANTX
Person: RA Capital Nexus Fund II10% Owner
Trade date: 24/08/09
Filed: 24/08/13
Days to filing: 4 days

Sold 66.4% of holdings

Share of holding sold: 66.4%

AN2 Therapeutics trades, last 26 weeks

What else happened in AN2 Therapeutics around then

Filed or reported within 30 days of the trade day · 24/07/10~24/09/08

RA Capital Nexus Fund II's recent trades

RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$45.7M
2,541,250 sh
$45.7M
Filed 05/06
Traded 05/04
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$2.4M
133,750 sh
$2.4M
Filed 05/06
Traded 05/04
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$2.1M
87,143 sh
$2.1M
Filed 05/06
Traded 05/05
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$1.3M
53,407 sh
$1.3M
Filed 05/06
Traded 05/06
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$347.3K
14,611 sh
$347.3K
Filed 05/06
Traded 05/06